SCHEMBL7670535

SCHEMBL7670535

O=C(Nc1ccc(S(=O)(=O)N[C@H](Cc2ccc(O)cc2)C(=O)O)cc1)c1ccccc1

nearest known ligand 0.87

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 9/20 0.87
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
L3MBTL1 Q9Y468 2/20 0.69
ITGB3 P05106 3/20 0.64
ITGAV P06756 3/20 0.64
ITGA2B P08514 3/20 0.64
ITGB1 P05556 2/20 0.64
ITGB5 P18084 2/20 0.64
MMP2 P08253 9/20 0.60
ADAMTS4 O75173 1/20 0.60
ALDH1A1 P00352 1/20 0.58
MAPT P10636 1/20 0.58
ADAMTS5 Q9UNA0 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MMP1 P03956 1/20 0.55
MMP3 P08254 1/20 0.55
MMP7 P09237 1/20 0.55
MMP13 P45452 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673966 1.00 MMP9 (0.87) MMP9MEN1KMT2AL3MBTL1ITGB3
SCHEMBL7668862 0.93 MMP9 (1.00) MMP9ITGB3ITGAVITGA2BITGB1
SCHEMBL7675244 0.93 MMP9 (1.00) MMP9ITGB3ITGAVITGA2BITGB1
SCHEMBL14191415 0.90 MMP9 (0.93) MMP9ITGB3ITGAVITGA2BITGB1
SCHEMBL7665147 0.88 MMP9 (0.71) MMP9MEN1KMT2AL3MBTL1ITGB3
SCHEMBL7663396 0.88 MMP9 (0.71) MMP9MEN1KMT2AL3MBTL1ITGB3
SCHEMBL5093780 0.85 MMP9 (1.00) MMP9ITGB3ITGAVITGA2BITGB1
SCHEMBL7669356 0.85 MMP9 (1.00) MMP9ITGB3ITGAVITGA2BITGB1
SCHEMBL8912956 0.85 L3MBTL1 (0.78) MMP9MEN1KMT2AL3MBTL1MMP2
SCHEMBL14191416 0.85 MMP9 (0.84) MMP9MEN1KMT2AL3MBTL1ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US claimed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed